Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02502474
Other study ID # 1408023
Secondary ID 2014-A00755-42
Status Completed
Phase N/A
First received
Last updated
Start date February 2, 2015
Est. completion date October 20, 2017

Study information

Verified date September 2018
Source Centre Hospitalier Universitaire de Saint Etienne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Epidemiological study aiming to describe the carriage (nasal, throat, groin, rectal and colonic) of S. aureus in patients without chronic digestive disease who are going to have a colonoscopy for cancer screening. The carriage will be analyzed globally and the similarity of strains isolated from each site will be analyzed using molecular tools. The aim of this study is to better estimate the digestive reservoir of S. aureus to better prevent endogenous infections due to this bacterium.


Recruitment information / eligibility

Status Completed
Enrollment 112
Est. completion date October 20, 2017
Est. primary completion date October 20, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Patient affiliated to French social security

- Written consent of the patient

- Patient needing a colonoscopy in the University Hospital of Saint-Etienne, France

Exclusion Criteria:

- Patient who decline to participate to the study

- Patient in the incapacity to give consent

- Patient receiving treatment with anticoagulant or antiaggregant platelets

- Patients with a known haemostatic disorder

- Pregnant woman

- Patients with a chronic disease of the gastrointestinal tract

- Patients receiving long-term corticosteroid

- Patient receiving anti staphylococcal antibiotics

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Staphylococcus aureus carriage
nasal, throat, rectal and groin sampling with swabs. Colonic sampling by colonic biopsy

Locations

Country Name City State
France CHU Saint-Etienne Saint-Etienne

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patient with Staphylococcus aureus colonic carriage Staphylococcus aureus carriage in the colon is measured by biopsy Day 1
Secondary Number of patient with similar Staphylococcus aureus strains in the nose and in the rectum Staphylococcus aureus carriage in the rectum and in the nose is measured by swab culture Day 1
Secondary Number of patient with Staphylococcus aureus carriage in the nose Staphylococcus aureus carriage in the nose is measured by swab culture. Day 1
Secondary Number of patient with Staphylococcus aureus carriage in the throat Staphylococcus aureus carriage in the throat is measured by swab culture. Day 1
Secondary Number of patient with Staphylococcus aureus carriage in the groin Staphylococcus aureus carriage in the groin is measured by swab culture. Day 1
See also
  Status Clinical Trial Phase
Completed NCT01447407 - Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine Phase 1
Recruiting NCT00518076 - Staphylococcus Aureus Carriers Students Nursing Oxacillin Resistant N/A
Completed NCT01324440 - Safety, Tolerability, and Immunogenicity of a Single Dose of Merck 0657nI Staphylococcus Aureus Vaccine With or Without Merck Aluminum Adjuvant (V710-002) Phase 1
Completed NCT00501150 - Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections N/A
Completed NCT00071214 - Study to Evaluate the Effectiveness of StaphVAX in Adults on Hemodialysis Phase 3
Completed NCT00063089 - Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever Phase 1/Phase 2
Completed NCT00175370 - Vancomycin Study: Treatment of Catheter Related Bloodstream Infection Caused by Coagulase Negative Staphylococcus N/A
Recruiting NCT03456544 - Vancomycin-Associated Acute Kidney Injury: A Cross-Sectional Study From a Multi- Center in China
Completed NCT02557568 - Evaluation of an Algorithm for Identifying Persistent Nasal Staphylococcus Aureus Carriage in a Cohort of Healthy Volunteers and Patients Regularly Monitored at the CHU of Saint-Etienne N/A
Terminated NCT01196169 - Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty Phase 4
Completed NCT01431326 - Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Completed NCT02971657 - Bacterial Phenotype of Staphylococcus Aureus Has no Effect on Patients` Clinical Outcome in Orthopedic Device Related Bone Infections N/A
Completed NCT02640937 - Biofilm Formation in Staphylococcus Epidermidis Associated Implant Infections N/A
Completed NCT00303069 - V710 First-In-Man (FIM) Study (V710-001) Phase 1
Completed NCT00156377 - Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections Phase 4
Completed NCT00631566 - Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons N/A
Completed NCT00113191 - Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants N/A
Completed NCT02782078 - Pharmacological Interaction of Rifampicin on Clindamycin in Staphylococcic Osteoarticular Infections N/A
Completed NCT00859677 - Immunologic Predisposition of HIV Patients to Develop Methicillin-Resistant Staphylococcus Aureus (MRSA) Colonization and Infection
Completed NCT00211900 - Evaluation of Manufacturing Lot of StaphVAX Phase 3